课题基金 / 基金详情

BRAIN HEALTH TOGETHER: A LIVE-STREAMING GROUP-BASED DIGITAL PROGRAM

BRAIN HEALTH TOGETHER: A LIVE-STREAMING GROUP-BASED DIGITAL PROGRAM
共同促进大脑健康:基于小组的直播数字节目
批准号:
10493302
负责人:
Deborah E. Barnes
金额:
$97.91万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-09-30 至 2024-05-31

项目摘要

项目成果

Deborah E. Barnes的其他基金

相似基金

相关文献

中文摘要
翻译
Together Senior Health,Inc.(一起)是一个妇女拥有的小企业,致力于帮助 认知能力下降或阿尔茨海默病及相关痴呆(ADRD)的老年人维持生活质量 通过提供创新的、基于证据的、在线的、直播的、团体的项目,我们的第一 Together音频/视频平台上的产品是Moving TogetherTM,它结合了动作, 通过正念身体意识练习和社交活动支持日常功能,旨在 轻度ADRD患者及其护理人员在家一起参与。这个的主要目标 第二阶段小企业创新研究(SBIR)赠款是扩大我们的产品线, 并为轻度认知障碍患者测试一项全面的大脑健康计划, 损害(MCI)。这一目标代表了我们公司从公众和 健康和商业前景。患有MCI的老年人代表了一个巨大的市场,具有重要的未满足的需求: 大约20%的老年人(> 270万美国人)目前患有MCI,这使他们在 发展ADRD的风险增加。没有药物可以预防ADRD的发展, MCI患者;然而,越来越多的证据表明,针对可改变的 痴呆症的危险因素--如缺乏运动、社交孤立和抑郁--可能有助于改善 认知功能,并可能延迟痴呆症的发作。我们的初步结果表明,我们的产品, 一起运动与认知功能,身体功能,社交功能, 隔离和自我调节以及静息状态前/后增加的默认模式网络连接 功能性磁共振成像(rs-fMRI)扫描与MCI的人。我们认为,这些好处 如果“一起行动”与全面的大脑健康指导相结合, 程序.因此,我们的具体目标是:1)与我们的科学顾问委员会合作, 以人为本的设计,为为期12周,以小组为基础, 直播,数字节目,将联合收割机一起移动与大脑健康教练,以解决 MCI患者中可改变的痴呆风险因素; 2)进行随机对照试验,以确定 脑健康共同计划是否在12周内改善MCI患者的认知功能 与成功老化对照组相比;以及3)确定每周维护课程是否 在干预后的12周内,帮助维持大脑健康计划的效果。如果我们能 证明大脑健康在以下方面具有立即和持续的认知益处: 与MCI的人,它将共同定位为循证计划的国家领导者, 提高老年认知障碍患者的生活质量并防止其衰退。
英文摘要
Together Senior Health, Inc. (TOGETHER) is a woman-owned small business that is dedicated to helping older adults with cognitive decline or Alzheimer’s disease and related dementias (ADRD) maintain quality of life and independence by offering innovative, evidence-based, online, livestream, group programs. Our first product on the TOGETHER audio/video platform is Moving TogetherTM—which combines movements to support daily function with mindful body awareness exercises and social engagement and is designed for people with mild ADRD and their caregivers who participate together from home. The primary goal of this Phase II Small Business Innovation Research (SBIR) grant is to expand our product line by developing and testing a comprehensive BRAIN HEALTH TOGETHER program for people living with mild cognitive impairment (MCI). This goal represents a critically important next step for our company from both public health and business perspectives. Older adults with MCI represent a large market with important unmet needs: approximately 20% of older adults (>2.7 million Americans) are currently living with MCI, which places them at increased risk of developing ADRD. There are no medications that can prevent development of ADRD in people with MCI; however, there is growing evidence that behavioral interventions targeting modifiable dementia risk factors—such as physical inactivity, social isolation, and depression—may help improve cognitive function and could potentially delay dementia onset. Our preliminary results suggest that our product, Moving Together is associated with significant improvements in cognitive function, physical function, social isolation, and self-regulation as well as increased default mode network connectivity on pre/post resting state functional magnetic resonance imaging (rs-fMRI) scans in people with MCI. We believe that these benefits would be even greater if Moving Together were combined with a comprehensive brain health coaching program. Therefore, our Specific Aims are to: 1) Work with our Scientific Advisory Board and use humancentered design to develop evidence-based content for Brain Health Together, a 12-week, group-based, livestreaming, digital program that will combine Moving Together with brain health coaching to address modifiable dementia risk factors in people with MCI; 2) Perform a randomized, controlled trial to determine whether the Brain Health Together program improves cognitive function in people with MCI over 12 weeks compared to a Successful Aging comparison group; and 3) Determine whether weekly maintenance classes help to sustain the effects of the Brain Health Together program over 12 weeks after the intervention. If we can demonstrate that BRAIN HEALTH TOGETHER has immediate and sustained cognitive benefits in people with MCI, it will position TOGETHER as a national leader in evidence-based programs to improve quality of life and prevent decline in older adults with cognitive impairment.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A Novel Algorithm to Identify People with Undiagnosed Alzheimer's Disease and Related Dementias
  • 批准号:
    10696912
  • 项目类别:
  • 资助金额:
    $153.55万
  • 财政年份:
    2023
  • 负责人:
    Deborah E. Barnes
  • 依托单位:
BRAIN HEALTH TOGETHER: A LIVE-STREAMING GROUP-BASED DIGITAL PROGRAM
  • 批准号:
    10747235
  • 项目类别:
  • 资助金额:
    $5.0万
  • 财政年份:
    2021
  • 负责人:
    Deborah E. Barnes
  • 依托单位:
BRAIN HEALTH TOGETHER: A LIVE-STREAMING GROUP-BASED DIGITAL PROGRAM
  • 批准号:
    10324919
  • 项目类别:
  • 资助金额:
    $150.5万
  • 财政年份:
    2021
  • 负责人:
    Deborah E. Barnes
  • 依托单位:
Identifying and supporting patients with undiagnosed dementia using the EHR Risk of Alzheimer's and Dementia Assessment Rule (eRADAR): a pilot clinical trial
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: